Natixis Advisors’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.01M | Buy |
|
|||||
|
2025
Q1 | $6.25M | Sell |
|
|||||
|
2024
Q4 | $6.34M | Buy |
|
|||||
|
2024
Q3 | $6.5M | Sell |
|
|||||
|
2024
Q2 | $6.06M | Sell |
|
|||||
|
2024
Q1 | $9.48M | Buy |
|
|||||
|
2023
Q4 | $9.36M | Sell |
|
|||||
|
2023
Q3 | $10.4M | Buy |
|
|||||
|
2023
Q2 | $10.4M | Sell |
|
|||||
|
2023
Q1 | $11.4M | Sell |
|
|||||
|
2022
Q4 | $11.2M | Sell |
|
|||||
|
2022
Q3 | $9.95M | Buy |
|
|||||
|
2022
Q2 | $8.68M | Buy |
|
|||||
|
2022
Q1 | $8.76M | Buy |
|
|||||
|
2021
Q4 | $5.5M | Sell |
|
|||||
|
2021
Q3 | $9.33M | Buy |
|
|||||
|
2021
Q2 | $8.85M | Buy |
|
|||||
|
2021
Q1 | $9.36M | Buy |
|
|||||
|
2020
Q4 | $5.82M | Buy |
|
|||||
|
2020
Q3 | $5.06M | Buy |
|
|||||
|
2020
Q2 | $4.79M | Sell |
|
|||||
|
2020
Q1 | $4.15M | Buy |
|
|||||
|
2019
Q4 | $4.17M | Buy |
|
|||||
|
2019
Q3 | $3.23M | Buy |
|
|||||
|
2019
Q2 | $2.5M | Sell |
|
|||||
|
2019
Q1 | $2.93M | Buy |
|
|||||
|
2018
Q4 | $1.45M | Buy |
|